GfK SE:企業の戦略・SWOT・財務分析

◆英語タイトル:GfK SE - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4357
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GfK SE – Strategy, SWOT and Corporate Finance Report
Summary

GfK SE – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GfK SE (GfK or “the company”) is a provider of market and consumer information designed for consumers to make informed decisions. Gfk provides services such as digital market intelligence, brand and customer experience, geomarketing, distribution and supply chain management, market opportunities and innovation, mystery shopping and media measurement, among others. It has business presence across Europe, the Americas, the Middle East, Africa and Asia Pacific. The company is headquartered in Nuremberg, Germany.

Scope

- Detailed information on GfK SE required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GfK SE in the form of a SWOT analysis
- An in-depth view of the business model of GfK SE including a breakdown and examination of key business segments
- Intelligence on GfK SE’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GfK SE, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GfK SE and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GfK SE as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GfK SE’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
GfK SE: Company Overview
GfK SE: Overview and Key Facts
GfK SE: Overview
GfK SE: Key Facts
GfK SE: Key Employees
GfK SE: Major Products and Services
GfK SE: Company History
GfK SE: Locations and Subsidiaries
GfK SE: Key Competitors
GfK SE: Company Analysis
GfK SE: Business Description
GfK SE: SWOT Analysis
GfK SE: SWOT Overview
GfK SE: Strengths
GfK SE: Weaknesses
GfK SE: Opportunities
GfK SE: Threats
GfK SE: Corporate Financial Deals Activity
GfK SE: Financial Deals Overview
GfK SE: Targets and Partners
GfK SE: Top Deals 2016 – 2020YTD*
GfK SE: Advisors
GfK SE: Top Legal Advisors
GfK SE: Top Financial Advisors
GfK SE: Mergers and Acquisitions
GfK SE: Divestments
GfK SE: Private Equity and Ownership
GfK SE: Recent Developments
GfK SE: News and Events Summary
GfK SE: Business Expansion
GfK SE: Corporate Governance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: GfK SE: Key Facts
Table 2: GfK SE: Key Employees
Table 3: GfK SE: Company History
Table 4: GfK SE: Locations and Subsidiaries
Table 5: GfK SE: Key Competitors
Table 6: GfK SE: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: GfK SE: Targets and Partners
Table 8: GfK SE: Top Deals 2016 - 2020YTD*
Table 9: GfK SE: Legal Advisor Ranking by Value (US$m)
Table 10: GfK SE: Financial Advisor Ranking by Value (US$m)
Table 11: GfK SE: M&A Volume and Value Trend (2016 - YTD*2020)
Table 12: GfK SE: M&A Activity by Geography (2016 - YTD*2020)
Table 13: GfK SE: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 14: GfK SE: Divestments by Geography (2016 - YTD*2020)
Table 15: GfK SE: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 16: GfK SE: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 17: GfK SE: News and Events Summary
Table 18: GfK SE: Business Expansion
Table 19: GfK SE: Corporate Governance

★海外企業調査レポート[GfK SE:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amkor Technology Inc (AMKR):企業の財務・戦略的SWOT分析
    Amkor Technology Inc (AMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • HoMedics USA LLC:企業の戦略的SWOT分析
    HoMedics USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • STMicroelectronics NV (STM):企業の財務・戦略的SWOT分析
    STMicroelectronics NV (STM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Intra-Cellular Therapies Inc (ITCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • Universities Superannuation Scheme Ltd:企業のM&A・事業提携・投資動向
    Universities Superannuation Scheme Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Universities Superannuation Scheme Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Lightbridge Corporation (LTBR)-エネルギー分野:企業M&A・提携分析
    Summary Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company, which develops thorium based nuclear fuel technologies for nuclear reactor systems, that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-h …
  • S&T Bancorp Inc:企業の戦略・SWOT・財務情報
    S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CaroGen Corp (CaroGen) is an immunotherapy company that offers platform technology development services. The company develops and commercializes virus-like vesicle based therapeutic vaccines. It utilizes its virus-like vesicle platform technology for the development of vaccines for infectiou …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Schibsted ASA:企業のM&A・事業提携・投資動向
    Schibsted ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Schibsted ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • First Light Biosciences Inc:企業の製品パイプライン分析2018
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Aminex PLC (AEX):企業の財務・戦略的SWOT分析
    Summary Aminex plc (Aminex) is an oil and gas company that explores, develops and produces oil and gas reserves in Africa. The company provides assets such as Valeni field and Viktorovka field in Moldova; West Esh el Mellaha-2 in Egypt; and Kiliwani North development, Nyuni exploration and Ruvuma ex …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dermapharm AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company offers products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, …
  • MedImmune LLC:企業の戦略的SWOT分析
    MedImmune LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Oriental Cuisines Private Limited
    Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report Summary Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆